Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Herzlich Willkommen!
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology,infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine. Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
ISBN: 9783031285356
Sprache: Englisch
Seitenzahl: 219
Produktart: Gebunden
Herausgeber: Myers, Alyson K.
Verlag: Springer International Publishing
Veröffentlicht: 11.06.2023
Untertitel: Considerations and Clinical Management
Schlagworte: CGM COVID-19 COVID Long-Haulers COVID Vaccine DKA Diabetes Diabetic Complications Diabetic Kidney Disease Diabetic Lung Disease HHS
Alyson K. Myers, MD, Division of Endocrinology, Department of Medicine, Montefiore Einstein, Bronx, NY

Das könnte Sie auch interessieren

Verwandte Artikel

Diabetes and COVID-19

107,00 CHF*